白花蛇舌草乙醇提取物对人肾癌细胞786-0体外增殖及小鼠肾癌细胞786-0移植瘤生长的影响

目的探讨白花蛇舌草乙醇提取物(EEHDH)对人肾癌786-0细胞体外增殖及小鼠肾癌细胞786-0移植瘤生长的影响。方法 (1)将人肾癌细胞786-0分为观察1、2、3、4组和对照组,观察1、2、3、4组分别加入终浓度为10、20、40、80 mg/L的EEHDH,对照组加入等体积培养液。培养24、48、72 h后采用MTT法于490 nm处测量吸光度值(OD490值)。(2)取42只昆明小鼠,随机分为7组,分别为模型组、EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组、对照组,每组6只。除对照组小鼠正常饲养不处理外,余36只小鼠每只左后肢腋...

Full description

Saved in:
Bibliographic Details
Published in山东医药 Vol. 57; no. 23; pp. 20 - 23
Main Author 张林超 赵俊峰 孙继建 潘世杰 高世玉 崔洪泉
Format Magazine Article
LanguageChinese
Published 河南中医药大学第二附属医院,郑州,450002 2017
Subjects
Online AccessGet full text
ISSN1002-266X
DOI10.3969/j.issn.1002-266X.2017.23.006

Cover

Abstract 目的探讨白花蛇舌草乙醇提取物(EEHDH)对人肾癌786-0细胞体外增殖及小鼠肾癌细胞786-0移植瘤生长的影响。方法 (1)将人肾癌细胞786-0分为观察1、2、3、4组和对照组,观察1、2、3、4组分别加入终浓度为10、20、40、80 mg/L的EEHDH,对照组加入等体积培养液。培养24、48、72 h后采用MTT法于490 nm处测量吸光度值(OD490值)。(2)取42只昆明小鼠,随机分为7组,分别为模型组、EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组、对照组,每组6只。除对照组小鼠正常饲养不处理外,余36只小鼠每只左后肢腋窝皮下接种0.2 mL肿瘤细胞悬液,24 h后称重。模型组灌胃等体积饮用水14 d;EEHDH低、中、高剂量组分别灌胃EEHDH 5.0、10.0、20.0 g/kg,1次/d,共14 d;环磷酰胺组每2 d灌胃1次20 mg/kg环磷酰胺,共灌胃7次;EEHDH中剂量联合环磷酰胺组在1、3、5天灌胃环磷酰胺20 mg/kg,第6天开始灌胃10.0 g/kg的EEHDH,1次/d,共9次。末次给药24 h后给各组小鼠称重,处死动物称瘤重,计算EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组抑瘤率。另分离各组小鼠胸腺、脾脏,精密称重,计算胸腺指数、脾脏指数。结果 (1)相同培养时间条件下观察1、2、3、4组人肾癌细胞786-0的OD490值与对照组相比均较低(P均〈0.05)。人肾癌细胞786-0的OD490值随着培养时间的延长和EEHDH剂量的增加而降低(P均〈0.05)。(2)实验结束时,模型组、EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组瘤重分别为(2.31±0.28)、(1.94±0.22)、(1.59±0.26)、(1.52±0.23)、(0.92±0.24)、(0.86±0.23)g,EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组抑瘤率分别为16.02%、31.22%、34.26%、60.20%、62.77%。EEHDH中剂量联合环磷酰胺Q值为0.87。模型组小鼠胸腺指数、脾脏指数与对照组相比均较高(P均〈0.05)。环磷酰胺组小鼠胸腺指数、脾脏指数
AbstractList R285.5; 目的 探讨白花蛇舌草乙醇提取物(EEHDH)对人肾癌786-0细胞体外增殖及小鼠肾癌细胞786-0移植瘤生长的影响.方法 ①将人肾癌细胞786-0分为观察1、2、3、4组和对照组,观察1、2、3、4组分别加入终浓度为10、20、40、80 mg/L的EEHDH,对照组加入等体积培养液.培养24、48、72 h后采用MTT法于490 nm处测量吸光度值(OD490值).②取42只昆明小鼠,随机分为7组,分别为模型组、EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组、对照组,每组6只.除对照组小鼠正常饲养不处理外,余36只小鼠每只左后肢腋窝皮下接种0.2 mL肿瘤细胞悬液,24 h后称重.模型组灌胃等体积饮用水14 d;EEHDH低、中、高剂量组分别灌胃EEHDH 5.0、10.0、20.0 g/kg,1次/d,共14 d;环磷酰胺组每2 d灌胃1次20 mg/kg环磷酰胺, 共灌胃7次;EEHDH中剂量联合环磷酰胺组在1、3、5天灌胃环磷酰胺20 mg/kg, 第6天开始灌胃10.0 g/kg的EEHDH,1次/d,共9次.末次给药24 h后给各组小鼠称重,处死动物称瘤重,计算EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组抑瘤率.另分离各组小鼠胸腺、脾脏,精密称重,计算胸腺指数、脾脏指数.结果 ①相同培养时间条件下观察1、2、3、4组人肾癌细胞786-0的OD490值与对照组相比均较低(P均<0.05).人肾癌细胞786-0的OD490值随着培养时间的延长和EEHDH剂量的增加而降低(P均<0.05).②实验结束时,模型组、EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组瘤重分别为(2.31±0.28)、(1.94±0.22)、(1.59±0.26)、(1.52±0.23)、(0.92±0.24)、(0.86±0.23)g,EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组抑瘤率分别为16.02%、31.22%、34.26 %、60.20%、62.77%.EEHDH中剂量联合环磷酰胺Q 值为0.87.模型组小鼠胸腺指数、脾脏指数与对照组相比均较高(P均<0.05).环磷酰胺组小鼠胸腺指数
目的探讨白花蛇舌草乙醇提取物(EEHDH)对人肾癌786-0细胞体外增殖及小鼠肾癌细胞786-0移植瘤生长的影响。方法 (1)将人肾癌细胞786-0分为观察1、2、3、4组和对照组,观察1、2、3、4组分别加入终浓度为10、20、40、80 mg/L的EEHDH,对照组加入等体积培养液。培养24、48、72 h后采用MTT法于490 nm处测量吸光度值(OD490值)。(2)取42只昆明小鼠,随机分为7组,分别为模型组、EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组、对照组,每组6只。除对照组小鼠正常饲养不处理外,余36只小鼠每只左后肢腋窝皮下接种0.2 mL肿瘤细胞悬液,24 h后称重。模型组灌胃等体积饮用水14 d;EEHDH低、中、高剂量组分别灌胃EEHDH 5.0、10.0、20.0 g/kg,1次/d,共14 d;环磷酰胺组每2 d灌胃1次20 mg/kg环磷酰胺,共灌胃7次;EEHDH中剂量联合环磷酰胺组在1、3、5天灌胃环磷酰胺20 mg/kg,第6天开始灌胃10.0 g/kg的EEHDH,1次/d,共9次。末次给药24 h后给各组小鼠称重,处死动物称瘤重,计算EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组抑瘤率。另分离各组小鼠胸腺、脾脏,精密称重,计算胸腺指数、脾脏指数。结果 (1)相同培养时间条件下观察1、2、3、4组人肾癌细胞786-0的OD490值与对照组相比均较低(P均〈0.05)。人肾癌细胞786-0的OD490值随着培养时间的延长和EEHDH剂量的增加而降低(P均〈0.05)。(2)实验结束时,模型组、EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组瘤重分别为(2.31±0.28)、(1.94±0.22)、(1.59±0.26)、(1.52±0.23)、(0.92±0.24)、(0.86±0.23)g,EEHDH低剂量组、EEHDH中剂量组、EEHDH高剂量组、环磷酰胺组、EEHDH中剂量联合环磷酰胺组抑瘤率分别为16.02%、31.22%、34.26%、60.20%、62.77%。EEHDH中剂量联合环磷酰胺Q值为0.87。模型组小鼠胸腺指数、脾脏指数与对照组相比均较高(P均〈0.05)。环磷酰胺组小鼠胸腺指数、脾脏指数
Abstract_FL Objective To investigate the effects of ethanol extracts of Hedyotis Diffusae Herba (EEHDH) on in-vitro proliferation of human renal cancer 786-0 cells and growth of mouse renal cancer 786-0 cell tumor xenograft.Methods ①Renal cancer 786-0 cells were divided into the observation groups 1, 2, 3, 4, and the control group.Cells in the observation groups 1, 2, 3, and 4 were respectively added with the final concentrations of 10, 20, 40, and 80 mg/L EEHDH, while cells in the control group were added with the same volume of culture fluid.We measured the OD490 of 490 nm at 24, 48, and 72 h after culture by MTT.②Forty-two Kunming mice were randomly divided into 7 groups: the model group, the low-dose EEHDH group, medium-dose EEHDH group, high-dose EEHDH group, the cyclophosphamide group, medium-dose EEHDH combined with cyclophosphamide group, and control group with six in each group.Except that the mice in the control group were normally fed, the rest of 36 mice were injected with 0.2 mL tumor cell suspension subcutaneously at left hind leg axillae and weighed at 24 h.Mice in the model control group were given the same volume of drinking wate by gavage for 14 d.Mice in the low-, medium-, and high-dose EEHDH groups were given 5.0, 10.0, and 20.0 g/kg EEHDH, respectively, once a day, for 14 d.Mice in the cyclophosphamide group were given 20 mg/kg cyclophosphamide once every 2 days for 7 times.Mice in the medium-dose EEHDH combined with cyclophosphamide group were given 20 mg/kg CTX on day 1, 3, and 5, followed by 10.0 g/kg on day 6, once a day for 9 times.At 24 h after the last administration, we killed the mice to weigh and calculate the anti-tumor rate in each group.Then we separated the thymuses and spleens, weighed precisely, and calculated the thymus index and spleen index.Results ①Under the same conditions, the OD490 of renal cancer 786-0 cells in the observation groups 1, 2, 3, and 4 was lower than that in the control group (all P<0.05).The OD490 of renal cancer 786-0 cells was reduced with the increased duration of incubation and increased EEHDH dose (all P<0.05).②At the end of the experiment, the tumor weight in the model group, the low-dose EEHDH group, medium-dose EEHDH groups, high-dose EEHDH group, cyclophosphamide group, and medium-dose EEHDH combined with cyclophosphamide group was respectively (2.31±0.28), (1.94±0.22), (1.59±0.26), (1.52±0.23), (0.92±0.24), (0.86±0.23) g.The inhibitory rates of the low-dose EEHDH group, medium-dose EEHDH groups, high-dose EEHDH group, cyclophosphamide group, and medium-dose EEHDH combined with cyclophosphamide group were 16.02%, 31.22%, 34.26%, 60.20%, and 62.77%, respectively.The Q value of the median-dose EEHDH was 0.87.The mouse thymus index and spleen index of the model group were higher than those of the control group (both P<0.05).The mouse thymus index and spleen index of the thymophosphamide group were lower than those of the model group (both P<0.05).The spleen index of the low-, medium-, and high-doses EEHDH groups was higher than that of the model group (P<0.05), and no significant difference was found in the mouse thymus index as compared with that of the model group (P>0.05).The mouse thymus index and spleen index of the medium-dose EEHDH combined with cyclophosphamide group were higher than that of the cyclophosphamide group (both P<0.05).Conclusion EEHDH can significantly inhibit the proliferation of human renal carcinoma 786-0 cells in vitro and inhibit the growth of mouse renal cancer 786-0 cell transplantation tumor in vivo.through the enhancement of spleen function.
Author 张林超 赵俊峰 孙继建 潘世杰 高世玉 崔洪泉
AuthorAffiliation 河南中医药大学第二附属医院,郑州450002
AuthorAffiliation_xml – name: 河南中医药大学第二附属医院,郑州,450002
Author_FL CUI Hongquan
SUN Jijian
GAO Shiyu
ZHANG Linchao
ZHAO Junfeng
PAN Shijie
Author_FL_xml – sequence: 1
  fullname: ZHANG Linchao
– sequence: 2
  fullname: ZHAO Junfeng
– sequence: 3
  fullname: SUN Jijian
– sequence: 4
  fullname: PAN Shijie
– sequence: 5
  fullname: GAO Shiyu
– sequence: 6
  fullname: CUI Hongquan
Author_xml – sequence: 1
  fullname: 张林超 赵俊峰 孙继建 潘世杰 高世玉 崔洪泉
BookMark eNplkEtLAlEAhe_CILX-RLRoM9N9zNw7swzpBUIbF-3kOg8f1FgOEW4rNEWZwJIssAgh2lQu1aw_43jHf9GE0abVgcPHOZwTAxGn6FgArCIoE53q6wU577qOjCDEEqZ0X8YQMRkTGUIaAdE_fxHEXLcAoYIR06PAFZ1xUO8H99XgshE0a5NBZ1apTr0r32uL2ov_NpgMh8HZp-g0xKgSnHeZRiU4Gbf8Xtt_6k5f275X99-92cfjP0o8j6a9prjtieuH2c2XuLvwx32_1VwCCzY_cK3lX42D1NZmKrEjJfe2dxMbScmgkEmahZRMhpqI2hxahCJma0xXoKWqlkW4QQ2NqBjpFoaKAU3F5MQIJ3HEFUVXFZXEwdo89pQ7Nney6ULxpOSEhWk3xx2zXP55CBMIWYiuzFEjV3Syx_kQPirlD3mpnKYMM10Ni8g3QpuP0Q
ClassificationCodes R285.5
ContentType Magazine Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1002-266X.2017.23.006
DatabaseName 中文期刊服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Effects of ethanol extracts of Hedyotis Diffusae Herba on in-vitro proliferation of human renal cancer 786-0 cells and growth of mouse renal cancer 786-0 cell tumor xenograft
DocumentTitle_FL Effects of ethanol extracts of Hedyotis Diffusae Herba on in-vitro proliferation of human renal cancer 786-0 cells and growth of mouse renal cancer 786-0 cell tumor xenograft
EndPage 23
ExternalDocumentID shandyy201723007
672795521
GrantInformation_xml – fundername: 河南省中医药科学研究专项课题
  funderid: (2014ZY02050)
GroupedDBID -05
2B.
2C~
2RA
5XA
5XF
92F
92I
92L
ABDBF
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CQIGP
CW9
EOJEC
OBODZ
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
ABJNI
ACUHS
PSX
ID FETCH-LOGICAL-c607-8e14bb6d16fa0e3617f87940e55ee3ac6c835219e204c0d4da3c179a1a4495453
ISSN 1002-266X
IngestDate Thu May 29 04:06:27 EDT 2025
Wed Feb 14 09:59:37 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 23
Keywords renal carcinoma
antitumor
白花蛇舌草
immunoregulation
免疫调节
肾癌
抗肿瘤
Hedyotis Diffusae Herba
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c607-8e14bb6d16fa0e3617f87940e55ee3ac6c835219e204c0d4da3c179a1a4495453
Notes Hedyotis Diffusae Herba;renal carcinoma;immunoregulation;antitumor
37-1156/R
Objective To investigate the effects of ethanol extracts of Hedyotis Diffusae Herba (EEHDH) on in-vitro proliferation of human renal cancer 786-0 cells and growth of mouse renal cancer 786-0 cell tumor xenograft.Methods ①Renal cancer 786-0 cells were divided into the observation groups 1, 2, 3, 4, and the control group.Cells in the observation groups 1, 2, 3, and 4 were respectively added with the final concentrations of 10, 20, 40, and 80 mg/L EEHDH, while cells in the control group were added with the same volume of culture fluid.We measured the OD490 of 490 nm at 24, 48, and 72 h after culture by MTT.②Forty-two Kunming mice were randomly divided into 7 groups: the model group, the low-dose EEHDH group, medium-dose EEHDH group, high-dose EEHDH group, the cyclophosphamide group, medium-dose EEHDH combined with cyclophosphamide group, and control group with six in each group.Except that the mice in the control group were normally fed,
PageCount 4
ParticipantIDs wanfang_journals_shandyy201723007
chongqing_primary_672795521
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 山东医药
PublicationTitleAlternate Shandong Medical Journal
PublicationTitle_FL Shandong Medical Journal
PublicationYear 2017
Publisher 河南中医药大学第二附属医院,郑州,450002
Publisher_xml – name: 河南中医药大学第二附属医院,郑州,450002
SSID ssj0042179
ssib001104105
ssib017477535
ssib051371736
ssib002262813
Score 1.3325998
Snippet 目的探讨白花蛇舌草乙醇提取物(EEHDH)对人肾癌786-0细胞体外增殖及小鼠肾癌细胞786-0移植瘤生长的影响。方法 (1)将人肾癌细胞786-0分为观察1、2、3、4组和对照组,观...
R285.5; 目的 探讨白花蛇舌草乙醇提取物(EEHDH)对人肾癌786-0细胞体外增殖及小鼠肾癌细胞786-0移植瘤生长的影响.方法 ①将人肾癌细胞786-0分为观察1、2、3、4组和对照组,观...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 20
SubjectTerms 免疫调节
抗肿瘤
白花蛇舌草
肾癌
Title 白花蛇舌草乙醇提取物对人肾癌细胞786-0体外增殖及小鼠肾癌细胞786-0移植瘤生长的影响
URI http://lib.cqvip.com/qk/92062X/201723/672795521.html
https://d.wanfangdata.com.cn/periodical/shandyy201723007
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9RAEG8QEuOTGjUiajBhn8hh_2zb3cfutRdiok-Y8HZp93rwdIjAAzyqASGQM0GJaIKGkBhfVB4B0S9D6fEtnNmWUtEQMWmayc72N7MzvZuZdneraQOs6UjHNKIKo6xRoTGNKpFpy4oRG9Jt0BByWFyN_PCRM_yYPhi1R7subJZmLc1MR0Ny7q_rSv7Hq9AGfsVVsufwbAEKDUCDf-EMHobzP_mYBC7hnAifBIwwjwgDCS4IVPjYAkdVET5hnASUCI79A06Yo_rAuUa4TgJbEQ4CQk-PY4tXw_54lYcH4phEBLlQRHaJEAiFLItAWcqciq6u8Am3FAZVqECYwEeBXpC3gEBQGQihIw1KiSrx9HPIcYmnOIhKcZB4BUMaCZCsUDlIqKkWjzCqBPrKUjbqyPxyeq64huLCIMCUVaVpVUlRdvSKmdCqb6axg2PjyuYCTGoPKsrGA3GKgVow1kFlDV_5QWkPY0CeABsPIhTajh3LdxS4n10HjhG_88BbAThMYQqKY0YASjxPETA8Xn6sY7ilxzpZJMJQZWafeSxCVbaXd_6TNK1y4NFLKUzGOR0cLe5wFRwRf6jAx-mN7pCJG_2e2pNcZTn4pp7bNu7V0GNC5ITg1-MJX9ROkm6o6I1S1ICE3mQnSSKUvC7UxAXfNiyc-eEc50sUimKu5iTkCl3UBnJt75-lK26GMj7RGpuEFE-tuGs1w9ZYKTkcuaJdPt6lvd_LfqNXta658WvaVLq-31na7rxf6Lxc7qwsHuysH80vHLZfJe21dPFz8nXnYHe38-xHur6c7s13nm-o-_pgfzXZWks2Nw6_rCXtpeRb--j7xz96pZ_2DrdW0rdb6esPR29-pu9eJPvbyerKdW2kFoxUhyv5R04q0tEhQYwNGkVOw3CaoR5bUE80GYRIPbbtOLZC6UgskQwemzqVeoM2QkuCvUIjpJRD9WPd0LpbE634ptZvhAAV6zKKmKRc2jyWke0244YurUZoyF6trzBY_Um2l029cG-vdi83YT3_h5uqT-HLu9lZNLppQTFx60yEPu3SyY18W-uefjoT34GMfTq6m98yvwBFzcAB
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%99%BD%E8%8A%B1%E8%9B%87%E8%88%8C%E8%8D%89%E4%B9%99%E9%86%87%E6%8F%90%E5%8F%96%E7%89%A9%E5%AF%B9%E4%BA%BA%E8%82%BE%E7%99%8C%E7%BB%86%E8%83%9E786-0%E4%BD%93%E5%A4%96%E5%A2%9E%E6%AE%96%E5%8F%8A%E5%B0%8F%E9%BC%A0%E8%82%BE%E7%99%8C%E7%BB%86%E8%83%9E786-0%E7%A7%BB%E6%A4%8D%E7%98%A4%E7%94%9F%E9%95%BF%E7%9A%84%E5%BD%B1%E5%93%8D&rft.jtitle=%E5%B1%B1%E4%B8%9C%E5%8C%BB%E8%8D%AF&rft.au=%E5%BC%A0%E6%9E%97%E8%B6%85+%E8%B5%B5%E4%BF%8A%E5%B3%B0+%E5%AD%99%E7%BB%A7%E5%BB%BA+%E6%BD%98%E4%B8%96%E6%9D%B0+%E9%AB%98%E4%B8%96%E7%8E%89+%E5%B4%94%E6%B4%AA%E6%B3%89&rft.date=2017-01-01&rft.issn=1002-266X&rft.volume=57&rft.issue=23&rft.spage=20&rft.epage=23&rft_id=info:doi/10.3969%2Fj.issn.1002-266X.2017.23.006&rft.externalDocID=672795521
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F92062X%2F92062X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fshandyy%2Fshandyy.jpg